Published in AIDS Weekly, May 13th, 1996
Researcher Chris Beyrer and colleagues found, however, that men recently released from the army did not respond favorably to the HBV vaccine program, suggesting that they would not make a good HIV vaccine cohort.
HIV-1 vaccines will eventually be evaluated in large-scale efficacy trials among persons at risk for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.